Filtered By:
Therapy: Alternative and Complementary Therapies
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 320 results found since Jan 2013.
The Role of Cobalamin on Interleukin 10, Osteopontin, and Related MicroRNAs in Multiple Sclerosis
Iran J Allergy Asthma Immunol. 2022 Jun 18;21(3):332-343. doi: 10.18502/ijaai.v21i3.9806.ABSTRACTMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS). Considering how vitamin B12 or cobalamin affects the immune system, especially inflammation and the formation of the myelin sheath, it appears as a complementary therapy for MS by affecting some signaling pathways. Recently diagnosed MS patients were divided into two groups (n=30). One group received interferon-beta (IFN-β or Avonex), and another received IFN-β+B12 for six months. Blood samples were taken before and after treatments...
Source: Iranian Journal of Allergy, Asthma and Immunology - July 13, 2022 Category: Allergy & Immunology Authors: Mohammad Sadegh Hesamian Vahid Shaygannejad Marjan Golabi Omid Mirmosayyeb Alireza Andalib Nahid Eskandari Source Type: research
Clinical Effect of Standardized Dietary Avoidance Therapy on Children with Milk Protein Allergy and Its Effect on Intestinal Flora
CONCLUSION: The standardized dietary avoidance therapy is remarkable in the treatment of CMPA, in which the children were able to tolerate ordinary milk earlier, and the intestinal flora was significantly improved, thereby promoting the growth and development of children. It therefore merits clinical promotion.PMID:35978994 | PMC:PMC9377903 | DOI:10.1155/2022/3362374
Source: Evidence-based Complementary and Alternative Medicine - August 18, 2022 Category: Complementary Medicine Authors: Wenying Hao Chun Zhu Yibo Chen Haibo Li Shufang Zhu Xiaojun Wang Source Type: research
The Role of Cobalamin on Interleukin 10, Osteopontin, and Related MicroRNAs in Multiple Sclerosis
Iran J Allergy Asthma Immunol. 2022 Jun 18;21(3):332-343. doi: 10.18502/ijaai.v21i3.9806.ABSTRACTMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS). Considering how vitamin B12 or cobalamin affects the immune system, especially inflammation and the formation of the myelin sheath, it appears as a complementary therapy for MS by affecting some signaling pathways. Recently diagnosed MS patients were divided into two groups (n=30). One group received interferon-beta (IFN-β or Avonex), and another received IFN-β+B12 for six months. Blood samples were taken before and after treatments...
Source: Iranian Journal of Allergy, Asthma and Immunology - July 13, 2022 Category: Allergy & Immunology Authors: Mohammad Sadegh Hesamian Vahid Shaygannejad Marjan Golabi Omid Mirmosayyeb Alireza Andalib Nahid Eskandari Source Type: research
Clinical Effect of Standardized Dietary Avoidance Therapy on Children with Milk Protein Allergy and Its Effect on Intestinal Flora
CONCLUSION: The standardized dietary avoidance therapy is remarkable in the treatment of CMPA, in which the children were able to tolerate ordinary milk earlier, and the intestinal flora was significantly improved, thereby promoting the growth and development of children. It therefore merits clinical promotion.PMID:35978994 | PMC:PMC9377903 | DOI:10.1155/2022/3362374
Source: Evidence-based Complementary and Alternative Medicine - August 18, 2022 Category: Complementary Medicine Authors: Wenying Hao Chun Zhu Yibo Chen Haibo Li Shufang Zhu Xiaojun Wang Source Type: research
The Role of Cobalamin on Interleukin 10, Osteopontin, and Related MicroRNAs in Multiple Sclerosis
Iran J Allergy Asthma Immunol. 2022 Jun 18;21(3):332-343. doi: 10.18502/ijaai.v21i3.9806.ABSTRACTMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS). Considering how vitamin B12 or cobalamin affects the immune system, especially inflammation and the formation of the myelin sheath, it appears as a complementary therapy for MS by affecting some signaling pathways. Recently diagnosed MS patients were divided into two groups (n=30). One group received interferon-beta (IFN-β or Avonex), and another received IFN-β+B12 for six months. Blood samples were taken before and after treatments...
Source: Iranian Journal of Allergy, Asthma and Immunology - July 13, 2022 Category: Allergy & Immunology Authors: Mohammad Sadegh Hesamian Vahid Shaygannejad Marjan Golabi Omid Mirmosayyeb Alireza Andalib Nahid Eskandari Source Type: research
